Delbary-Gossart; Sandrine

Patent Applications and Registrations

Patent applications and USPTO patent grants for Delbary-Gossart; Sandrine.The latest application filed is for "novel (heterocycle/condensed piperidine)-(piperazinyl)-1-alkanone or (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alkanone derivatives and use thereof as p75 inhibitors".

Company Profile

0.10.8

Delbary-Gossart; Sandrine - Mauzac FR
Delbary-Gossart; Sandrine - Paris FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
(Heterocycle/condensed piperidine)-(piperazinyl)-1-alkanone or (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alkanone derivatives and use thereof as p75 inhibitors Grant 8,957,211 - Baroni , et al. February 17, 2	2015-02-17
(heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors Grant 8,906,924 - Baroni , et al. December 9, 2	2014-12-09
NOVEL (HETEROCYCLE/CONDENSED PIPERIDINE)-(PIPERAZINYL)-1-ALKANONE OR (HETEROCYCLE/CONDENSED PYRROLIDINE)-(PIPERAZINYL)-1-ALKANONE DERIVATIVES AND USE THEREOF AS p75 INHIBITORS App 20140038946 - BARONI; Marco ; et al.	2014-02-06
NOVEL (HETEROCYCLE/TETRAHYDROPYRIDINE)-(PIPERAZINYL)-1-ALCANONE AND (HETEROCYCLE/DIHYDROPYRROLIDINE)-(PIPERAZINYL)-1-ALCANONE DERIVATIVES, AND USE THEREOF AS p75 INHIBITORS App 20130303520 - BARONI; Marco ; et al.	2013-11-14
(Heterocycle/condensed piperidine)-(piperazinyl)-1-alkanone or (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alkanone derivatives and use thereof as p75 inhibitors Grant 8,580,790 - Baroni , et al. November 12, 2	2013-11-12
Derivatives of (bridged piperazinyl)-1-alkanone and use thereof as p75 inhibitors Grant 8,519,143 - Baroni , et al. August 27, 2	2013-08-27
(Heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors Grant 8,518,947 - Baroni , et al. August 27, 2	2013-08-27
Derivatives Of 2-oxoalkyl-1-piperazin-2-one, Preparation Method Thereof And Therapeutic Use Of Same App 20120289518 - BARONI; Marco ; et al.	2012-11-15
NOVEL (HETEROCYCLE/CONDENSED PIPERIDINE)-(PIPERAZINYL)-1-ALKANONE OR (HETEROCYCLE/CONDENSED PYRROLIDINE)-(PIPERAZINYL)-1-ALKANONE DERIVATIVES AND USE THEREOF AS p75 INHIBITORS App 20120245149 - BARONI; Marco ; et al.	2012-09-27
NOVEL (HETEROCYCLE/TETRAHYDROPYRIDINE)-(PIPERAZINYL)-1-ALCANONE AND (HETEROCYCLE/DIHYDROPYRROLIDINE)-(PIPERAZINYL)-1-ALCANONE DERIVATIVES, AND USE THEREOF AS p75 INHIBITORS App 20120245150 - BARONI; Marco ; et al.	2012-09-27
DERIVATIVES OF (BRIDGED PIPERAZINYL)-1-ALKANONE AND USE THEREOF AS p75 INHIBITORS App 20120232280 - BARONI; Marco ; et al.	2012-09-13
Derivatives of 2-oxoalkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same Grant 8,247,404 - Baroni , et al. August 21, 2	2012-08-21
Derivatives of (bridged piperazinyl)-1-alkanone and use thereof as p75 inhibitors Grant 8,193,190 - Baroni , et al. June 5, 2	2012-06-05
Derivatives Of 2-oxoalkyl-1-piperazin-2-one, Preparation Method Thereof And Therapeutic Use Of Same App 20110144122 - BARONI; Marco ; et al.	2011-06-16
DERIVATIVES OF (BRIDGED PIPERAZINYL)-1-ALKANONE AND USE THEREOF AS p75 INHIBITORS App 20110144116 - BARONI; Marco ; et al.	2011-06-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.